XORTX Therapeutics Inc. filed a Form 6-K on October 22, 2025, reporting financial agreements dated October 21, 2025, including a Placement Agency Agreement and a Securities Purchase Agreement. This filing may represent a significant event for the company, classified under restructuring and reorganizations, with a neutral sentiment.